Human Genome ends development of Zalbin - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Human Genome ends development of Zalbin
BusinessWeek
Human Genome Sciences Inc. said Tuesday it is ending development of the potential hepatitis C drug Zalbin in anticipation of a Food and Drug Administration request for more information on its application for approval of the drug. ...
Novartis takes $590M hit as HGS ditches hep C drug ZalbinFierceBiotech
Human Genome Sciences junks ZalbinWashington Business Journal
Human Genome, Novartis Halt Development Of Hepatitis C DrugWall Street Journal
Genetic Engineering News -TheStreet.com -MarketWatch (press release)
all 38 news articles &raquo;


More...